Citations

Showing 10 of 108119 citations.

A National Contemporary Analysis of Perioperative Outcomes for Vaginal Vault Prolapse: Minimally Invasive Sacrocolpopexy Versus Nonmesh Vaginal Surgery
Linder, Brian J. , Gershman, Boris , Bews, Katherine A. , Glasgow, Amy E. , Occhino, John A. , Glasgow, Amy E. , Glasgow, Amy E , Linder, Brian J

Mayo Clinic

Female Pelvic Medicine & Reconstructive Surgery | January 19, 2019 | Volume: 25 | Issue: 5 | Pages: 342-346

10.1097/spv.0000000000000678 | PMID 30628947 Get It

Objective The aim of this study was to compare the perioperative morbidity of minimally invasive sacrocolpopexy (MISC) and nonmesh apical vaginal surgeries for repair of vaginal vault prolapse using data from a contemporary nationwide cohort. Methods The American College of Surgeons' National Surgical Quality Improvement Program database was used to identify women who underwent apical prolapse surgery via vaginal approach or MISC from 2010 to 2016. Those undergoing concomitant hysterectomy or transvaginal mesh placement were excluded. Associations of surgical approach with 30-day complications, prolonged hospitalization, and reoperation were evaluated using logistic regression. Readmission within 30 days was calculated using the person-years method and Cox proportional hazards models. Results Overall, 6390 women underwent surgery, including 3852 (60%) via vaginal approach and 2538 (40%) via MISC. Patients undergoing MISC were younger ( P < 0.0001) and less likely to have hypertension ( P = 0.04) or chronic obstructive pulmonary disease ( P = 0.008), with lower American Society of Anesthesiologists scores ( P < 0.0001) and higher preoperative hematocrit ( P = 0.009). The MISC cohort had a lower unadjusted rates of minor complications (3.9% vs 5.6%; P = 0.004), urinary tract infection (3.3% vs 4.8%; P = 0.004), and prolonged hospitalization (5.2% vs 7.9%; P < 0.0001), with a higher rate of nephrologic ( P = 0.01) complications. On multivariable analysis, there were no significant associations of MISC with the risk of 30-day complications (odds ratio [OR], 1.51; 95% confidence interval [CI], 0.92–2.51; P = 0.11), prolonged hospitalization (OR, 0.96; 95% CI, 0.76–1.21; P = 0.72), readmission (HR 1.03; 95% CI, 0.71–1.49; P = 0.88), or reoperation (OR, 0.95; 95% CI, 0.57–1.60; P = 0.86). Conclusions Minimally invasive sacrocolpopexy is associated with similar rates of 30-day complications, prolonged hospitalization, readmission, and reoperation compared with nonmesh vaginal surgeries for apical prolapse.
Response to Chamberlin and Borody
Lichtenstein, Gary R. , Loftus, Edward V. , Isaacs, Kim L. , Loftus, Edward V , Regueiro, Miguel , Sands, Bruce E

Mayo Clinic

American Journal of Gastroenterology | January 19, 2019 | Volume: 114 | Issue: 1 | Pages: 171-174

10.14309/ajg.0000000000000077 | PMID 30633034 Get It

Response to Forrest et al.
Bataller, Ramón , Kamath, Patrick S. , Shah, Vijay H. , Bataller, Ramon A , Singal, Ashwani K. , Ahn, Joseph

Mayo Clinic

American Journal of Gastroenterology | January 19, 2019 | Volume: 114 | Issue: 1 | Pages: 176-176

10.14309/ajg.0000000000000073 | PMID 30633036 Get It

Neuroimaging findings in midlife and risk of late-life dementia over 20 years of follow-up
West, Nancy A., Windham, B. Gwen , Shibata, Dean , Coker, Laura H., Shibata, Dean K, Knopman, David S. , Mosley, Thomas H.

Mayo Clinic

Neurology | January 19, 2019 | Volume: 92 | Issue: 9 | Pages: No page available

10.1212/wnl.0000000000006989 | PMID 30659141 Get It

Comparison of Outcomes in Oncoplastic Pelvic Reconstruction with VRAM versus Omental Flaps: A Large Cohort Analysis
Chaudhry, Arif, Oliver, Jeremie D. , Vyas, Krishna S. , Tran, Nho V. , Martinez‐Jorge, Jorys, Dozois, Eric J. , Nelson, Heidi , Manrique, Oscar J. , Larson, David, Dozois, Eric, Oliver, Jeremie D , Larson, David W.

Mayo Clinic

Journal of Reconstructive Microsurgery | January 19, 2019 | Volume: 35 | Issue: 06 | Pages: 425-429

10.1055/s-0038-1677524 | PMID 30658351 Get It

Background The purpose of this study is to describe our experience and outcomes in oncoplastic pelvic reconstruction for patients who underwent either vertical rectus abdominis musculocutaneous (VRAM) or omental flap following abdominoperineal resection (APR) at a single tertiary care institution. Methods All patients who underwent pelvic reconstruction following APR with either VRAM or omental flaps from January 1992 to January 2017 were retrospectively reviewed. Patient demographics and relevant comorbidities including chemotherapy and radiation therapy data were collected and analyzed. In addition, margin status at the time of oncologic resection was analyzed. Flap-specific data were collected for each approach. Oncologic data collected included cancer type, stage at time of APR, and rate of tumor recurrence within the flap. Results A total of 562 patients were identified who underwent pelvic reconstruction with either VRAM or omental pedicle flaps. Of these, 274 (48.8%) underwent VRAM reconstruction and 288 (51.2%) underwent omental flap reconstruction. All margins were negative at time of cancer ablation surgery. Complications data included: seroma (VRAM = 2 [0.36%]; omentum = 32 [5.69%], p < 0.0001), wound dehiscence (VRAM = 31 [5.52%]; omentum = 17 [3.02%], p = 0.022), abscess (VRAM = 4 [0.71%]; omentum = 27 [4.8%], p < 0.0001), cellulitis (VRAM = 2 [0.36%]; omentum = 10 [1.78%], p = 0.025). Statistical comparison of tumor recurrence between these two reconstructive approaches showed a significantly higher recurrence rate in omental flaps compared with VRAM flaps (p = 0.000127). Conclusion The results of this study suggest a significantly higher tumor recurrence rate in omental flap pelvic reconstruction compared with VRAM flaps. This knowledge has the potential to influence surgical planning and flap selection in pelvic reconstruction.
Numbers Have Life: A Commentary on “Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit”
Le‐Rademacher, Jennifer , Jatoi, Aminah , Le-Rademacher, Jennifer G

Mayo Clinic

The Oncologist | January 18, 2019 | Volume: 24 | Issue: 4 | Pages: 433-434

10.1634/theoncologist.2018-0834 | PMID 30659080 Get It

The commentary remarks on a recently published article on a study that examined predictors of poor outcomes in cancer patients using the SOFA score, answering to the question of whether the results of the study can completely inform decisions about terminal care management.
Nearly complete deletion of BubR1 causes microcephaly through shortened mitosis and massive cell death
Simmons, Ambrosia , Park, Raehee, Sterling, Noelle A. , Jang, Mi‐Hyeon , Deursen, Jan M. A. van, Cho, Seo-Hee, van Deursen, Jan M A, Yen, Tim J. , Kim, Seonhee

Mayo Clinic

Human Molecular Genetics | January 18, 2019 | Volume: 28 | Issue: 11 | Pages: 1822-1836

10.1093/hmg/ddz022 | PMID 30668728 Get It

Abstract BUB-related 1 (BubR1) encoded by Budding Uninhibited by Benzimidazole 1B (BUB1B) is a crucial mitotic checkpoint protein ensuring proper segregation of chromosomes during mitosis. Mutations of BUB1B are responsible for mosaic variegated aneuploidy (MVA), a human congenital disorder characterized by extensive abnormalities in chromosome number. Although microcephaly is a prominent feature of MVA carrying the BUB1B mutation, how BubR1 deficiency disturbs neural progenitor proliferation and neuronal output and leads to microcephaly is unknown. Here we show that conditional loss of BubR1 in mouse cerebral cortex recapitulates microcephaly. BubR1-deficient cortex includes a strikingly reduced number of late-born, but not of early-born, neurons, although BubR1 expression is substantially reduced from an early stage. Importantly, absence of BubR1 decreases the proportion of neural progenitors in mitosis, specifically in metaphase, suggesting shortened mitosis owing to premature chromosome segregation. In the BubR1 mutant, massive apoptotic cell death, which is likely due to the compromised genomic integrity that results from aberrant mitosis, depletes progenitors and neurons during neurogenesis. There is no apparent alteration in centrosome number, spindle formation or primary cilia, suggesting that the major effect of BubR1 deficiency on neural progenitors is to impair the mitotic checkpoint. This finding highlights the importance of the mitotic checkpoint in the pathogenesis of microcephaly. Furthermore, the ependymal cell layer does not form in the conditional knockout, revealing an unrecognized role of BubR1 in assuring the integrity of the ventricular system, which may account for the presence of hydrocephalus in some patients.
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
Stock, Wendy , Luger, Selina M. , Yin, Jun , Mullighan, Charles G. , Fulton, Noreen, Laumann, Kristina, Malnassy, Greg, Paietta, Elisabeth , Parker, Edy, Geyer, Susan, Mrózek, Krzysztof , Bloomfield, Clara D. , Sanford, Ben L. , Marcucci, Guido , Liedtke, Michaela , Claxton, David F. , Bogart, Jeffrey A. , Grecula, J.C., Appelbaum, Frederick R. , Litzow, Mark R. , Tallman, Martin S. , Stone, Richard M. , Mullighan, Charles G , Claxton, David F , Stock, Wendy , Advani, Anjali S. , Harvey, Richard C. , Willman, Cheryl L. , Foster, Matthew C , Erba, Harry Paul , Larson, Richard A.

Mayo Clinic

Blood | January 18, 2019 | Volume: 133 | Issue: 14 | Pages: 1548-1559

10.1182/blood-2018-10-881961 | PMID 30658992 Get It

Abstract Retrospective studies have suggested that older adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) have better survival rates when treated using a pediatric ALL regimen administered by pediatric treatment teams. To address the feasibility and efficacy of using a pediatric treatment regimen for AYA patients with newly diagnosed ALL administered by adult treatment teams, we performed a prospective study, CALGB 10403, with doses and schedule identical to those in the Children's Oncology Group study AALL0232. From 2007 to 2012, 318 patients were enrolled; 295 were eligible and evaluable for response. Median age was 24 years (range, 17-39 years). Use of the pediatric regimen was safe; overall treatment-related mortality was 3%, and there were only 2 postremission deaths. Median event-free survival (EFS) was 78.1 months (95% confidence interval [CI], 41.8 to not reached), more than double the historical control of 30 months (95% CI, 22-38 months); 3-year EFS was 59% (95% CI, 54%-65%). Median overall survival (OS) was not reached. Estimated 3-year OS was 73% (95% CI, 68%-78%). Pretreatment risk factors associated with worse treatment outcomes included obesity and presence of the Philadelphia-like gene expression signature. Use of a pediatric regimen for AYAs with ALL up to age 40 years was feasible and effective, resulting in improved survival rates compared with historical controls. CALGB 10403 can be considered a new treatment standard upon which to build for improving survival for AYAs with ALL. This trial was registered at www.clinicaltrials.gov as #NCT00558519.
Evaluation of Parathyroid Glands with Indocyanine Green Fluorescence Angiography After Thyroidectomy
Rudin, Anatoliy V. , McKenzie, Travis J. , Thompson, Geoffrey B. , Farley, David R. , Lyden, Melanie L.

Mayo Clinic

World Journal of Surgery | January 18, 2019 | Volume: 43 | Issue: 6 | Pages: 1538-1543

10.1007/s00268-019-04909-z | PMID 30659346 Get It

AbstractBackgroundIndocyanine green fluorescence angiography (ICGA) is a new adjunct that has been used in surgical procedures to assess blood flow. This study evaluated the utility of ICGA compared to visual inspection to predict parathyroid function, guide autotransplantation and potentially decrease permanent hypoparathyroidism.MethodsThis was a retrospective study of patients who underwent total or near‐total thyroidectomy (T‐NT) between January 2015 and March 2018. Patients with preoperative hyperparathyroidism and those undergoing reoperation were excluded. Patients who had ICGA were compared to T‐NT patients without ICGA. Data were analyzed to assess the frequency of autotransplantation and incidence of hypoparathyroidism between groups.ResultsIn total, 210 patients underwent T‐NT: 86 with ICGA and 124 without. Autotransplantation was more common in the ICGA group at 36% compared to 12% in the control (p = 0.0001). There was no correlation with at least one normal parathyroid gland on ICGA and postoperative PTH levels (p = 0.75). There was a difference in having normal postoperative PTH when there were at least two normal parathyroid glands (n = 50) compared to patients with less than two normal ICGA glands (n = 36, p = 0.044). Visual assessment and ICGA assessment of vascularity were in agreement, 245/281 (87%). There were 19 glands (6.8%) that would have undergone autotransplant based on visual inspection that had adequate blood supply on ICGA. Transient hypoparathyroidism was present in 45 out of 124 controls (36%) and 32 out of 86 (37%) in the ICG group.ConclusionsICGA is a novel technique that may improve the assessment of parathyroid gland blood supply compared to visual inspection. ICGA can guide more appropriate autotransplantation without compromising postoperative parathyroid function. At least two vascularized glands on ICGA may predict postoperative parathyroid gland function.